0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editorial |

Antipsychotics and Increased Mortality Are We Sure?

Mark S. Baron, MD1,2
[+] Author Affiliations
1Department of Neurology, Virginia Commonwealth University Health System, Richmond
2Southeast Parkinson’s Disease Research, Education, and Clinical Center, Hunter Holmes McGuire Veterans Affairs Medical Center, Richmond, Virginia
JAMA Neurol. 2016;73(5):502-504. doi:10.1001/jamaneurol.2016.0213.
Text Size: A A A
Published online

Extract

In 2005, based on a review of 17 placebo-controlled trials of second-generation antipsychotics (APs) (olanzapine, aripiprazole, risperidone, and quetiapine fumarate), the US Food and Drug Administration (FDA) suggested that the use of atypical APs carries a 1.6- to 1.7-times higher incidence of mortality in elderly, demented people.1 However, the purported increased deaths could not be attributed to specific causes, and cardiac problems (heart failure or sudden death) and infections (mostly pneumonia) were considered to be the largest contributors. In addition to issuing a public health advisory, the FDA henceforth required manufacturers of all atypical APs to include a black box warning to their labeling indicating that these agents (1) are not approved for treatment of psychosis in elderly patients with dementia and (2) carry an increased mortality risk. In 2008, the FDA extended the warning to first-generation APs, concluding that “elderly patients with dementia-related psychosis treated with conventional or atypical antipsychotic drugs are at an increased risk of death.”2

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

1,264 Views
0 Citations
×

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles
Jobs
JAMAevidence.com

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Parkinsonism

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Make the Diagnosis: Parkinsonism

brightcove.createExperiences();